Dr. Karl Gene Stonecipher, MD

Dr. Stonecipher practices at Eagle Endoscopy and Colonoscopy Center in Greensboro, North Carolina.

Dr. Stonecipher's NPI, 1427172246, was assigned on March 19, 2007. Dr. Stonecipher graduated from University of Oklahoma College of Medicine in 1986. Dr. Stonecipher holds North Carolina license 34914.

Dr. Stonecipher's primary practice is Eagle Endoscopy and Colonoscopy Center, at 1002 North Church Street, Suite 2, Greensboro, NC 27401. The practice phone is (336) 268-3880.

Dr. Stonecipher's primary practice is Eagle Endoscopy and Colonoscopy Center in Greensboro, North Carolina. Dmand AI also links Dr. Stonecipher to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stonecipher practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Stonecipher's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Stonecipher is licensed in North Carolina.

CMS data shows 562 Medicare services from Dr. Stonecipher across 10 procedure codes in 2024, for 167 Medicare patients. Medicare paid $69,541 for them.

CMS counts 167 Medicare patients who saw Dr. Stonecipher in 2024. The largest group is 65 to 74, with 99 patients. 74% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stonecipher's median patient age at 72, with 54% women.

In 2024, Dr. Stonecipher wrote 1,216 Medicare Part D claims for 376 patients. 39% of them were for generic drugs. CMS names the drug for 1,113 of them, across 19 drugs with 11 or more claims each, at $1,755,790 in total drug cost. In 2023, CMS named 961 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Stonecipher for performance year 2024, reported as part of a group. Dr. Stonecipher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 195 procedures of cataract surgery by Dr. Stonecipher, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Stonecipher, published from 2013 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Refraction, Ocular, Astigmatism and Keratomileusis, Laser In Situ. Dr. Stonecipher has published most often in J Cataract Refract Surg. Dr. Stonecipher's most frequent co-authors are Mitchell Alin Jackson, MD, Richard S. Davidson, MD and Kendall E. Donaldson, MD.

Dmand AI links Dr. Stonecipher to 2 clinical trials. Conditions studied include Dry Eye Syndromes, Presbyopia and Lacrimal Apparatus Diseases.

CMS Open Payments shows 1,473 general payments to Dr. Stonecipher from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Alcon Laboratories Inc paid the most, $262,304. It also lists 26 research payments totaling $48,725 from 2020 to 2021.

Dr. Stonecipher graduated from University of Oklahoma College of Medicine in 1986.